GB586645A - Improvements relating to the synthesis of amino acid derivatives and salts thereof - Google Patents

Improvements relating to the synthesis of amino acid derivatives and salts thereof

Info

Publication number
GB586645A
GB586645A GB1378244A GB1378244A GB586645A GB 586645 A GB586645 A GB 586645A GB 1378244 A GB1378244 A GB 1378244A GB 1378244 A GB1378244 A GB 1378244A GB 586645 A GB586645 A GB 586645A
Authority
GB
United Kingdom
Prior art keywords
carbon atoms
acid
methoxy
alkoxy
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1378244A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Burroughs Wellcome Co USA
Burroughs Wellcome and Co USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Burroughs Wellcome Co USA, Burroughs Wellcome and Co USA Inc filed Critical Burroughs Wellcome Co USA
Priority to GB1378244A priority Critical patent/GB586645A/en
Publication of GB586645A publication Critical patent/GB586645A/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compounds of general formula <FORM:0586645/IV/1> wherein both R1 and R2 represent H, or one represents H and the other alkyl (1 to 2 carbon atoms), R3 represents H or alkyl (1 to 5 carbon atoms), R4 represents alkoxy or hydroxy alkylamino (1 to 5 carbon atoms), R5 represents alkoxy (1 to 5 carbon atoms), R6 represents H, halogen or alkyl (1 to 2 carbon atoms) or alkoxy (1 to 5 carbon atoms), R5 and R6 together represent methylenedioxy, R7 represents H or halogen, n is either zero or 1, and X represents an alkylene radical containing from 2 to 6 carbon atoms, of which at least 2 are in the direct chain connecting the nitrogen atom with the-COR4 group, and salts thereof, are obtained (when R4 represents alkoxy), by treating a secondary phenalkylamine substituted in the ring at least once with alkoxy (1 to 5 carbon atoms) and having at least 2 carbon atoms in a hydrocarbon chain between the phenyl group and the nitrogen atom with an aliphatic acid ester (3 to 7 carbon atoms), which acid is either substituted by halogen on a carbon atom at least once removed from the carboxy group, or which is an a b -unsaturated acid. Preferably, the reactants are dissolved in a mutual solvent, being refluxed after standing for at least 2 hours and conveniently the product is acidified, extracted with a solvent, treated with an alkali and re-acidified to isolate the requisite acid salt. The foregoing esters are converted to amides, e.g. by treatment with an alkylolamine. Where, in the phenalkylamine reactant, R3 represents benzyl, or other aralkyl radical, it may be eliminated from the ester obtained, by catalytic hydrogenation. The products are stabilized as salts, e.g. hydrochlorides, sulphates, phosphates, tartrates, malates, succinates or hydrobromides. The Specification contains a list of phenalkyl compounds which may be prepared in accordance with the process of the invention. Numerous examples of the process of the invention are given. d -(3 : 4-Dimithoxyphenyl)-n-hexylmethylamine is obtained by effecting a Friedel-Crafts reaction of veratrole with the linear anhydride of pimelic acid, catalytically hydrogenating the resulting e -veratroyl caproic acid to d -veratryl heptanoic acid, converting this product, through its ethyl ester, to the corresponding hydrazide, which is converted to d -veratryl n-hexylamine, and to the final product by the Decker method. 3-Methoxy-4-n-propoxyphenethylamine is obtained by propylating vanillin to 3-methoxy-4-n-propoxybenzaldehyde and proceeding as in the synthesis of homoveratrylamine. b -(2-Methoxy-5-methyl)-phenylethylamine is obtained by treating 2 - methoxy - 5 - methyl phenylaldehyde with malonic acid and piperidine in pyridine, the product being reduced by sodium amalgam to 2-methoxy-5-methyl hydrocinnamic acid, treated with ammonia at 220 DEG C. to obtain the corresponding amide, followed by treatment with sodium hypochlorite and sodium hydroxide to obtain the desired product. The Provisional Specification discloses many additional products which may also be obtained in accordance with the process of the invention.
GB1378244A 1944-07-19 1944-07-19 Improvements relating to the synthesis of amino acid derivatives and salts thereof Expired GB586645A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1378244A GB586645A (en) 1944-07-19 1944-07-19 Improvements relating to the synthesis of amino acid derivatives and salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1378244A GB586645A (en) 1944-07-19 1944-07-19 Improvements relating to the synthesis of amino acid derivatives and salts thereof

Publications (1)

Publication Number Publication Date
GB586645A true GB586645A (en) 1947-03-26

Family

ID=10029272

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1378244A Expired GB586645A (en) 1944-07-19 1944-07-19 Improvements relating to the synthesis of amino acid derivatives and salts thereof

Country Status (1)

Country Link
GB (1) GB586645A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2886594A (en) * 1954-12-27 1959-05-12 Sterling Drug Inc N-(2-carbamylalkyl)-aralkylamines
FR2531950A1 (en) * 1982-08-20 1984-02-24 Midit O-AMINO ACID AMIDE DERIVATIVES, THEIR PREPARATION, USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS AND CARDIOVASCULAR DISORDERS, AND COMPOSITIONS CONTAINING SAME
EP0289070A1 (en) * 1987-04-10 1988-11-02 Duphar International Research B.V Tertiary arylethyl amine derivatives having opiate-antagonistic activity
WO2007071311A1 (en) * 2005-12-22 2007-06-28 Newron Pharmaceuticals S.P.A. 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
WO2008151702A1 (en) * 2007-06-15 2008-12-18 Newron Pharmaceuticals S.P.A. Substituted 2- [2- (phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2886594A (en) * 1954-12-27 1959-05-12 Sterling Drug Inc N-(2-carbamylalkyl)-aralkylamines
FR2531950A1 (en) * 1982-08-20 1984-02-24 Midit O-AMINO ACID AMIDE DERIVATIVES, THEIR PREPARATION, USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS AND CARDIOVASCULAR DISORDERS, AND COMPOSITIONS CONTAINING SAME
EP0289070A1 (en) * 1987-04-10 1988-11-02 Duphar International Research B.V Tertiary arylethyl amine derivatives having opiate-antagonistic activity
NO341296B1 (en) * 2005-12-22 2017-10-02 Newron Pharm Spa 2-phenylethylamino derivatives such as calcium and / or sodium channel modulators
WO2007071311A1 (en) * 2005-12-22 2007-06-28 Newron Pharmaceuticals S.P.A. 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
US7855227B2 (en) 2005-12-22 2010-12-21 Newron Pharmaceuticals S.P.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
US8129427B2 (en) 2005-12-22 2012-03-06 Newron Pharmaceuticals S.P.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
CN101309909B (en) * 2005-12-22 2012-11-14 纽朗制药有限公司 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
US8470877B2 (en) 2005-12-22 2013-06-25 Newron Pharmaceuticals S.P.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
WO2008151702A1 (en) * 2007-06-15 2008-12-18 Newron Pharmaceuticals S.P.A. Substituted 2- [2- (phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
US8519000B2 (en) 2007-06-15 2013-08-27 Newron Pharmaceuticals S.P.A. Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
US9051240B2 (en) 2007-06-15 2015-06-09 Newron Pharmaceuticals S.P.A. Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
US9248116B2 (en) 2007-06-15 2016-02-02 Newron Pharmaceuticals S.P.A. Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
US9474737B2 (en) 2007-06-15 2016-10-25 Newron Pharmaceuticals S.P.A. Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
US9474738B2 (en) 2007-06-15 2016-10-25 Newron Pharmaceuticals S.P.A. Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
US9474739B2 (en) 2007-06-15 2016-10-25 Newron Pharmaceuticals S.P.A. Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
US9585869B2 (en) 2007-06-15 2017-03-07 Newron Pharmaceuticals, S.P.A. Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
US9603832B2 (en) 2007-06-15 2017-03-28 Newron Pharmaceuticals S.P.A. Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators
EA018195B1 (en) * 2007-06-15 2013-06-28 Ньюрон Фармасьютикалс С.П.А. Substituted 2-[2-(phenyl)ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators

Similar Documents

Publication Publication Date Title
US2451436A (en) Method of preparing n-alkyl acrylamides
ES482365A1 (en) Process for the preparation of 1-desoxy-nojirimicyn and N-substituted derivatives.
GB586645A (en) Improvements relating to the synthesis of amino acid derivatives and salts thereof
IE41440B1 (en) 7-methoxy-6-thiatetracyclines and their preparation
NO170154C (en) PROCEDURE FOR THE PREPARATION OF QUINOLINCARBOXYLIC ACIDS
GR3001816T3 (en) Process for the preparation of thienylethyl amines, and dithienylethyl amines so obtained
GB989193A (en) Process for the production of heterocyclic nitrogen compounds
US2617808A (en) 4-thiazolidone-2-n-caproates and preparation thereof
GB1601701A (en) Production of heterocyclic benzamide compounds
JPS5645498A (en) Manufacture of 66aminoo66desoxyy2*33oo isopropylideneealphaall sorbofuranose derivative and novel intermediate product
US4229582A (en) Process for the preparation of sterically uniform, natural 6-thiatetracycline derivatives
GB749907A (en) Improvements in bis-(p-aminophenoxy) alkane derivatives
US2857398A (en) Succinimide compounds and method for obtaining the same
ES8200092A1 (en) Esters of N-(4&#39;-hydroxyphenyl)acetamide with 5-benzoyl-1-methylpyrrole-2-acetic acids.
CH609667A5 (en) Process for the preparation of acetic acid derivatives
GB1411666A (en) Tetrahydro-1,4-oxazines and process for preparing the same
GB1041015A (en) Improvements in or relating to spiropiperidyl-succinimide derivatives
RU2165409C2 (en) Method of preparing bis-n,n(3,5-di-tert-butyl-4- oxybenzyl)methylamine
GB2038824A (en) Preparation of 3-methyl-2- (carboxy-???-hydroxyethylamido)- quinoxaline-1,4-dioxides
GB1067782A (en) Aldimines
GB563665A (en) Manufacture of heterocyclic bases
ATE155125T1 (en) PRODUCTION OF DOBUTAMIN COMPOUNDS
GB726069A (en) Succinimide compounds and method for obtaining the same
GB879576A (en) Improvements in and relating to alkanoic acids and salts thereof
GB1506913A (en) Process for the preparation of 2-phenylamino-2-imidazoline derivatives